Certain amidophenyl-sulfonylamino-quinoxaline compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.

 
Web www.patentalert.com

< Benzamidazoles, compositions containing such compounds and methods of use

> Modified release formulations of a bupropion salt

> Heterocyclic cannabinoid receptor antagonists
~ 00534